Brillance Sp. z o.o. is a Polish, fully independent and privately owned boutique CRO (Contract Research Organization). We provide comprehensive support in the planning, management and monitoring of clinical development projects for pharmaceutical and biotechnology companies, as well as medical device manufacturers. Our independence enables flexibility and a tailored approach to every project while maintaining high ethical and scientific standards and full compliance with Good Clinical Practice (GCP).
The company’s core activity is research and development in medical sciences and pharmacy, with a particular focus on the management and monitoring of Phase I–IV clinical trials of medicinal products across multiple therapeutic areas. Our experience includes patient-based Phase I studies across several therapeutic areas and medical device clinical investigations documented since 2008.
We deliver both local studies and complex international projects. We also support research sites in preparing for participation in clinical trials, conduct feasibility assessments, provide training and offer staff outsourcing.
Clinical trials assess the efficacy and safety of medicinal products and medical devices and support the development and availability of new treatment options. We believe that well-conducted clinical research drives innovative therapies that meaningfully improve patients’ quality of life and survival outcomes.
